アタイ・ベックリー
Atai Beckley N.V
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.13 | $953,999 | -$21M |
| 2025 Q4 | -2.45 | $1M | -$48M |
| 2025 Q3 | -0.28 | $749,000 | -$29M |
| 2025 Q2 | -0.14 | $719,000 | -$19M |
| 2025 Q1 | -0.15 | $2M | -$18M |
| 2024 Q4 | -0.24 | -$5,000 | -$24M |
| 2024 Q3 |
| -0.16 |
| $40,000 |
| -$19M |
| 2024 Q2 | -0.36 | $273,000 | -$16M |